Telehealth visits for lung disease linked to connective tissue disease
Part of Bones, joints & muscles, Immune system & allergy, Lungs & breathing clinical trials.
This study offers remote (telehealth) visits with lung specialists for people in rural New York who have a lung condition linked to connective tissue disease. The goal is to improve access to care and help manage the disease without long travel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed lung disease (interstitial lung disease) linked to a connective tissue disease, such as scleroderma, lupus, or rheumatoid arthritis, diagnosed at least one year ago.
- You live full-time in one of these New York counties: St. Lawrence, Franklin, Jefferson, Lewis, Hamilton, Clinton, or Essex.
- You are able to do breathing tests (pulmonary function tests) and lab work at a nearby facility.
- You are not already seeing a lung specialist at an academic medical center for this condition.
- If you could become pregnant, you must use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies lung scans (HRCT) from patients with rheumatoid arthritis, interstitial lung disease, or connective tissue disease to better understand lung involvement. If you have one of these conditions and have had a lung CT, you may be able to help.
This trial tests new treatments for people with scleroderma-related lung disease. You may be eligible if you have systemic sclerosis with lung scarring, your symptoms started within the last 7 years, and you have not had certain prior treatments or transplants.
This registry collects health and breathing test information from adults with autoimmune-related lung scarring (interstitial lung disease) diagnosed recently. It helps researchers better understand who has this condition and how it changes over time.
This trial tests whether people with lung disease caused by a rheumatic condition can safely manage their care at home using a smartphone or tablet. It aims to see if home monitoring is as effective as in-person visits for keeping your lungs healthy.
This study looks at people aged 18 and older who have a connective tissue disease and lung involvement. It aims to better understand how these lung problems progress and may help doctors choose better care.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
Hear when a new Interstitial Lung Disease Due to Systemic Disease (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.